Classification Models for Anticancer Activity

Author(s): R. Dutt, A.K. Madan

Journal Name: Current Topics in Medicinal Chemistry

Volume 12 , Issue 24 , 2012

Become EABM
Become Reviewer


Despite significant research in understanding of neoplastic diseases, the success rate for oncology drugs is relatively very low. A major challenge before the scientific community is to design new chemical entities that will be highly selective for cancer cells so as to minimize side effects. Classification models (CMs) models play a prominent role in prediction of the biological properties of newly designed compounds before their synthesis and prevent non-optimal use of resources. Though correlation models far outnumber classification models for development of various therapeutic agents but the significance of classification models for development of anti-cancer agents can not be underestimated. Various techniques employed for development of classification models for anti-cancer activity have been briefly reviewed. Moreover, successful use of some of these classification techniques for the development of models for anti-proliferative activity has been illustrated using a data set comprising of 53 analogues of N-Benzoylated phenoxazines and phenothiazines. Resulting classification models with high degree of accuracy can play a vital role in providing lead structures for the development of novel anti-proliferative agents for cancer chemotherapy.

Keywords: Classification modelling, molecular descriptors, random forest, moving average analysis, decision tree, anticancer agents, classification techniques

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 13 March, 2013
Page: [2705 - 2726]
Pages: 22
DOI: 10.2174/1568026611212240002

Article Metrics

PDF: 51